000 01725 a2200481 4500
005 20250518100033.0
264 0 _c20210728
008 202107s 0 0 eng d
022 _a2162-4011
024 7 _a10.1080/2162402X.2020.1722022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScanvion, Quentin
245 0 0 _aModerate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.
_h[electronic resource]
260 _bOncoimmunology
_c2020
300 _a1722022 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAntineoplastic Agents, Immunological
650 0 4 _aDatabases, Factual
650 0 4 _aHumans
650 0 4 _aHypereosinophilic Syndrome
_xchemically induced
650 0 4 _aImmune Checkpoint Inhibitors
650 0 4 _aPharmacovigilance
700 1 _aBéné, Johana
700 1 _aGautier, Sophie
700 1 _aGrandvuillemin, Aurélie
700 1 _aLe Beller, Christine
700 1 _aChenaf, Chouki
700 1 _aEtienne, Nicolas
700 1 _aBrousseau, Solenn
700 1 _aCortot, Alexis B
700 1 _aMortier, Laurent
700 1 _aStaumont-Sallé, Delphine
700 1 _aMorschhauser, Franck
700 1 _aForestier, Alexandra
700 1 _aGroh, Matthieu
700 1 _aLaunay, David
700 1 _aHachulla, Eric
700 1 _aLabalette, Myriam
700 1 _aKahn, Jean-Emmanuel
700 1 _aLefèvre, Guillaume
773 0 _tOncoimmunology
_gvol. 9
_gno. 1
_gp. 1722022
856 4 0 _uhttps://doi.org/10.1080/2162402X.2020.1722022
_zAvailable from publisher's website
999 _c30880191
_d30880191